참고문헌
Bae, Kyun-Seop. 2018. Nmw: Understanding Nonlinear Mixed Effects Modeling for Population Pharmacokinetics. https://CRAN.R-project.org/package=nmw.
Beal, Sheiner, S. L. 2018. NONMEM 7.4 Users Guides. Gaithersburg, Maryland: ICON plc. https://nonmem.iconplc.com/nonmem743/guides.
Bonate, Peter. 2011. Pharmacokinetic-Pharmacodynamic Modeling and Simulation. New York: Springer. https://www.springer.com/gp/book/9781441994844.
Brendel, K., C. Dartois, E. Comets, A. Lemenuel-Diot, C. Laveille, B. Tranchand, P. Girard, C. M. Laffont, and F. Mentre. 2007. “Are population pharmacokinetic and/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004.” Clin Pharmacokinet 46 (3): 221–34.
Derendorf, H, and B Meibohm. 1999. “Modeling of Pharmacokinetic/Pharmacodynamic (PK/PD) Relationships: Concepts and Perspectives.” Pharmaceutical Research 16 (2): 176–85. https://doi.org/10.1023/a:1011907920641.
Draper, Norman. 1998. Applied Regression Analysis. New York: Wiley.
Ette, Ene. 2007. Pharmacometrics : The Science of Quantitative Pharmacology. Hoboken, N.J: John Wiley & Sons. https://onlinelibrary.wiley.com/doi/book/10.1002/0470087978.
Gabrielsson, Johan. 2006. Pharmacokinetic & Pharmacodynamic Data Analysis : Concepts and Applications. Stockholm: Apotekarsocieteten.
Han, Seunghoon, Sangil Jeon, and Dong-Seok Yim. 2016. “Tips for the Choice of Initial Estimates in NONMEM.” Translational and Clinical Pharmacology 24 (3): 119–23.
Harling, Uekcert, K. 2018. VPC and NPC User Guide. ICON plc. https://github.com/UUPharmacometrics/PsN/releases/download/4.9.0/vpc_npc_userguide.pdf.
Helmlinger, Gabriel, Nidal Al-Huniti, Sergey Aksenov, Kirill Peskov, Karen M Hallow, Lulu Chu, David Boulton, et al. 2017. “Drug-Disease Modeling in the Pharmaceutical Industry - Where Mechanistic Systems Pharmacology and Statistical Pharmacometrics Meet.” European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences 109S (November): S39–46. https://doi.org/10.1016/j.ejps.2017.05.028.
Holford, N. 2010. Differential Equation Models Using NM-TRAN. Auckland, New Zealand: University of Auckland; University of Auckland. http://holford.fmhs.auckland.ac.nz/docs/differential-equations.pdf.
Hooker, Andrew C., Mats O. Karlsson, Justin J. Wilkins, and E. Niclas Jonsson. 2020. Xpose4: Diagnostics for Nonlinear Mixed-Effect Models. https://CRAN.R-project.org/package=xpose4.
Lee, Jongtae, Seunghoon Han, Sangil Jeon, Taegon Hong, and Dong-Seok Yim. 2013. “Pharmacokinetic–Pharmacodynamic Model of Fimasartan Applied to Predict the Influence of a High Fat Diet on Its Blood Pressure-Lowering Effect in Healthy Subjects.” European Journal of Clinical Pharmacology 69 (1): 11–20.
Lee, Joomi, Yangha Hwang, Wonku Kang, Sook Jin Seong, Mi-sun Lim, Hae Won Lee, Dong-Seok Yim, Dong Ryul Sohn, Seunghoon Han, and Young-Ran Yoon. 2012. “Population Pharmacokinetic/Pharmacodynamic Modeling of Clopidogrel in Korean Healthy Volunteers and Stroke Patients.” The Journal of Clinical Pharmacology 52 (7): 985–95.
Owen, Fiedler-Kelly, J. 2014. Introduction to Population Pharmacokinetic/Pharmacodynamic Analysis with Nonlinear Mixed Effects Models. Hoboken, New Jersey: Wiley. https://onlinelibrary.wiley.com/doi/book/10.1002/9781118784860.
Pinheiro, Jose, Douglas Bates, and R-core. 2020. Nlme: Linear and Nonlinear Mixed Effects Models. https://CRAN.R-project.org/package=nlme.
Post, Teun M, Jan I Freijer, Bart A Ploeger, and Meindert Danhof. 2008. “Extensions to the Visual Predictive Check to Facilitate Model Performance Evaluation.” Journal of Pharmacokinetics and Pharmacodynamics 35 (2): 185.
Primary Psychiatry. 2013. From Symptom Palliation to Disease Modification: Implications for Dementia Care. http://primarypsychiatry.com/from-symptom-palliation-to-disease-modification-implications-for-dementia-care/.
Savic, Karlsson, R. M. 2007. Shrinkage in Empirical Bayes Estimates for Diagnostics and Estimation: Problems and Solutions. Uppsala, Sweden: Uppsala University; Uppsala University. https://www.page-meeting.org/pdf_assets/9436-EBE_PAGE07_1_web.pdf.
Sharma, A, and W J Jusko. 1998. “Characteristics of Indirect Pharmacodynamic Models and Applications to Clinical Drug Responses.” British Journal of Clinical Pharmacology 45 (3): 229–39. https://doi.org/10.1046/j.1365-2125.1998.00676.x.
Yano, Yoshitaka, Stuart L Beal, and Lewis B Sheiner. 2001. “Evaluating Pharmacokinetic/Pharmacodynamic Models Using the Posterior Predictive Check.” Journal of Pharmacokinetics and Pharmacodynamics 28 (2): 171–92.
Zhang, Liping, Stuart L Beal, and Lewis B Sheiner. 2003a. “Simultaneous vs. Sequential Analysis for Population PK/PD Data I: Best-Case Performance.” Journal of Pharmacokinetics and Pharmacodynamics 30 (6): 387–404.
———. 2003b. “Simultaneous vs. Sequential Analysis for Population PK/PD Data II: Robustness of Methods.” Journal of Pharmacokinetics and Pharmacodynamics 30 (6): 405–16.
김우철. 2012. 수리통계학. 민영사. https://books.google.co.kr/books?id=yBOWtwAACAAJ.
식품의약품안전평가원 의약품심사부 종양약품과. 2015. 의약품 개발 시 집단 약동학 활용을 위한 가이드라인. http://www.nifds.go.kr/nifds/08_part/part03_c_b.jsp?mode=view&article_no=7038.